Jeanine

$Greenland Energy(GLND.US)

Context

I bought into the Greenland hype, and GLND ran further than I expected. I took partial profit on the way up, then held the rest to see whether the momentum would continue.

Then the price started to weaken. There were little pauses and rebounds, but they weren’t turning into the stronger recovery I was waiting for.

My Trade

I had a limit sell set slightly above the opening high and hoped a bounce would fill it. When GLND started slipping, I wanted to believe it could make its way back to my limit order. Instead, it kept drifting lower.

I eventually moved the limit sell down, but I waited too long and gave back more of the gains that had been right in front of me.

Of course, GLND bounced a little after I sold, just enough to make me question myself 😂 But it later fell as low as $3.98 postmarket. Getting out when I did was a good call, even if I wish I’d acted sooner.

Takeaway

Taking partial profit was the right call, and closing the rest protected the profit I still had. The part I want to improve is how long I waited to adjust my original limit order after the chart started telling a different story.

Trust the chart instead of hoping for a miracle. If the stock keeps slipping and my only reason to wait is “maybe the next bounce will reach my order,” I need to reassess sooner.

Green trade overall. Timely exit. Lesson learned with a completely unnecessary amount of drama. 🙃

$Taseko Mines(TGB.US)

Is a Copper Shortage Coming? 👀

CONTEXT

Copper is gaining attention as supply struggles to keep pace with growing demand from power grids, electrification, renewable energy and AI data centres.

The world hasn’t run out of copper, but the longer-term outlook is tightening. New mines can take years to develop, while existing producers face declining ore grades, rising costs and operational disruptions.

That makes TGB, formerly Taseko Mines, particularly interesting.

The company recently rebranded as Trekor Metals to reflect its growing business and expanded North American asset base. With Gibraltar already producing and Florence Copper ramping up, Trekor is evolving into a multi-asset producer just as concerns over future copper supply are intensifying.

The timing could prove significant. If copper becomes increasingly scarce, dependable production from stable North American operations may become even more valuable.

MY TRADE

This remains an open position in my Longbridge portfolio.

The stock has pushed through the psychological $9 level after repeatedly testing it. I’m now watching whether that former resistance can become support.

TAKEAWAY

A potential copper shortage supports the broader thesis, but a strong commodity story should not replace company-level research.

For now, I’m letting the trade play out while watching whether copper’s momentum and Trekor’s operational progress can support another leg higher.

1B 2A 3B

Since the 25bp hike is already expected, I’m not doing anything immediately. I’ll wait for the market drama to settle first. If they signal more hikes this year, I’ll stay cautious, but if this looks like a one-off hike, I may look for opportunities after the dip.

I favour cybersecurity in the near term because stricter AI safeguards should increase security spending. Longer term, chips remain essential infrastructure, so I would watch the pullback rather than abandon semiconductors completely.

When a Fast Scalp Became a Hold | $Tilly(TLYS.US)

Context:

TLYS caught my attention after its first-quarter earnings sparked a strong price move. Comparable sales increased 22.9%, revenue grew 15.9%, and the company reported improving margins alongside a substantially narrower loss.

Management also guided towards profitability in the following quarter, creating a possible post-earnings continuation setup.

My Trade:

I entered TLYS at $5.30, initially intending it to be a fast scalp. The momentum failed to continue and the position turned into a longer hold. I kept a good-til-cancelled sell order at $5.95 while waiting for the turnaround thesis to develop.

Following the company’s next earnings report, TLYS surged above $6 and filled my sell order at $5.95, securing approximately 12.3% profit.

Takeaway:

The improving-business thesis eventually played out, but not within my intended trading timeframe.

A profitable result does not necessarily mean the trade was managed perfectly. If I enter for a scalp, I need a clear invalidation level so that a short-term trade does not quietly become an indefinite hold.

In this case, patience and a pre-set exit produced a profitable outcome, but the capital could have remained trapped much longer if the next earnings report had disappointed.

$Butterfly Network(BFLY.US)

Context: I entered BFLY at $4.65 before the stock’s major run. In June, Midjourney Medical unveiled a full-body imaging platform using Butterfly’s ultrasound-on-chip technology, sending BFLY sharply higher. I trimmed half at $6.99 during the initial surge. After the catalyst attracted more attention and the rally continued, I added part of the position back at $8.30 during the subsequent pullback. Strong Q2 results later supported the move, with revenue increasing 39% year-on-year, gross margin reaching 71%, and management raising its full-year outlook.

My trade: Still holding, currently up 58.7%. The first trim secured profit, while the later addition restored some exposure after the Midjourney announcement changed the market’s expectations for the company.

Takeaway: Taking profit during a sudden spike helped manage risk, but trimming half immediately left me chasing part of the position back higher. Next time, I would scale out in smaller stages when a meaningful catalyst may continue driving the stock.

$Satellogic(SATL.US)

From Space Story to Operating Business?

Satellogic’s latest quarter may mark an important shift from speculative space story to a company showing real operating progress.

Q2 revenue rose 259% year over year to $15.9 million, while SATL reported its first positive operating income and adjusted EBITDA. Adjusted EBITDA reached $2.8 million, compared with a $3.9 million loss a year earlier.

The improvement came from both sides of the business. Data and Analytics contributed $7.1 million, while Space Systems generated $8.8 million as sovereign and defence demand expanded.

SATL also ended the quarter with $112.8 million in cash and $80.7 million in remaining performance obligations, giving it stronger liquidity and better visibility into future revenue.

Recent contract wins add weight to the story, including a $12 million sovereign satellite agreement and a separate defence-monitoring contract worth more than $18 million. The next major test is Merlin, SATL’s planned daily global-monitoring constellation. Its first launch is scheduled for October 2026, with full operational capability targeted for the first half of 2027.

The risks remain clear. One profitable quarter does not guarantee sustained profitability, revenue can still be contract-driven, and execution on Merlin will be critical. Still, SATL is beginning to look less like a concept and more like a business proving that growth can translate into operating leverage.

$AirJoule Tech(AIRJ.US) 🌧️💧

Real Commercial Catalyst or Another Small-Cap Spike?

AirJoule Technologies develops systems that extract water directly from the air, targeting regions where water infrastructure is costly, constrained or difficult to expand.

Its latest catalyst came from Kubota, which purchased two AirJoule Core systems for planned Q3 deployments in Texas and California. The companies also entered an exclusive US sales agreement focused on multi-unit residential developments.

This matters because AIRJ now has an established industrial partner helping test whether its technology can work as practical decentralised water infrastructure, not just a promising concept.

The deployments should generate real-world performance data across different environments. Successful results could support repeat orders, wider adoption and a clearer route toward commercial revenue.

However, this remains an early validation stage. Contract values and future purchase volumes were not disclosed. AIRJ is also loss-making, while recent equity financing keeps dilution risk in focus.

The stock’s surge, pullback and recovery reflect both sides of the story: genuine progress, but significant small-cap volatility.

I’m holding while watching whether these deployments begin on schedule and convert into larger orders. The catalyst is real. The next test is scalable revenue.

$Butterfly Network(BFLY.US)

The Bigger Story Is Starting to Show Up

Butterfly Network is best known for turning ultrasound into a handheld, whole-body imaging device powered by its proprietary Ultrasound-on-Chip technology.

The problem it is solving is access. Traditional ultrasound machines can be expensive, bulky and limited to specialised departments. Butterfly’s platform is designed to make medical imaging more portable and available closer to the patient.

Its latest Q2 results suggest that the story is beginning to show up in the numbers. Revenue reached $32.6 million, up 39% year over year, driven by particularly strong US demand. Gross margin also improved to 71.4%, helped by higher-margin Butterfly Embedded licensing revenue.

This is important because Butterfly may be evolving beyond simply selling handheld scanners. Its technology can also be licensed into third-party medical devices, potentially giving the company a more scalable and profitable revenue stream.

Recent developments support that broader thesis. Butterfly expanded into Brazil, while Embedded partner Aleph Neuro demonstrated brain-imaging results using Butterfly’s chip platform.

The risks remain. Butterfly is still loss-making, cash burn matters, and strong post-earnings expectations can make the stock volatile. But compared with the June story, there is now more evidence that rising demand and Embedded licensing are beginning to strengthen both revenue growth and margins.

I’m still holding my remaining BFLY shares while watching whether this momentum continues through stronger Embedded revenue, international growth and improving profitability. The bigger Butterfly story may finally be moving from possibility to measurable progress.

$AirJoule Tech(AIRJ.US)

AIRJ develops atmospheric water technology designed to extract water from the air using a highly efficient dehumidification process.

The problem it is trying to solve is straightforward: many regions face water scarcity, ageing infrastructure and rising demand, while conventional water supply can be expensive, energy-intensive or difficult to expand. AirJoule’s technology aims to create a decentralised source of water that can be deployed closer to where it is needed.

The company recently gained attention after AirJoule and Kubota announced an exclusive residential sales agreement, alongside planned water-from-air deployments in Texas and California.

That matters because it gives AIRJ something more concrete than a futuristic technology story. Kubota brings industrial credibility, while the planned deployments provide a real-world test of whether the technology can move from early commercial interest towards wider adoption.

The stock surged as high as about $4.75 before giving back a large part of the move, showing just how volatile small-cap catalyst trades can be.

The bull case is simple: successful deployments could lead to further installations, broader distribution and eventually meaningful revenue. The risk is that commercial rollout is still early, the company remains loss-making, and recent financing has kept dilution concerns in focus.

So the catalyst looks genuine, but execution will determine whether AIRJ becomes more than a headline trade.

*For informational purposes only. Not investment advice.

$SATS(S58.SG)

SATS has climbed to S$4.73 and is holding at a new 52-week high.

Its latest growth plan involves AI and “F1-style telemetry” across its global aviation and cargo network. But the real opportunity is not the buzzword—it is operating leverage.

SATS runs a large, complex network where small improvements in staffing, cargo flow and aircraft turnaround times can add up quickly. If the platform reduces delays and improves asset utilisation, revenue does not need to rise dramatically for margins to expand.

That matters because SATS is moving from recovery into optimisation. Aviation demand and cargo volumes have improved, earnings are recovering, and analysts have raised their targets. The next stage is proving that its expanded global footprint can generate better returns, not merely more revenue.

The risk is that the stock has already reached a fresh high, so investors are beginning to price in successful execution.

My view: the AI strategy could become a genuine margin catalyst, but the next earnings report must show measurable productivity gains. Otherwise, the headline may have moved faster than the fundamentals.

$AMC ENT(AMC.US) 🍿🎬

AMC Entertainment surged after reporting a much stronger-than-expected second quarter.

Revenue increased 14.2% year-on-year to a record US$1.60 billion, while adjusted earnings reached US$0.14 per share, beating expectations for a loss. Adjusted EBITDA also jumped approximately 70% to US$321.4 million, and AMC generated US$190.1 million in free cash flow as cinema attendance recovered strongly.

The results were supported by a stronger blockbuster slate and higher demand for premium cinema formats. More than 4.3 million moviegoers also visited AMC and Odeon locations during the opening weekend of The Odyssey, providing further momentum heading into the next quarter.

AMC still carries substantial debt and dilution risk, so one record quarter does not completely resolve its longer-term challenges. However, the sharp improvement in earnings, attendance and free cash flow suggests that the cinema recovery is finally translating into stronger operating performance.

I will be watching whether this momentum can continue through the upcoming film slate.

$PepGen(PEPG.US)

PIPELINE, FINANCIALS & PRICE OUTLOOK

PepGen’s 5 mg/kg Phase 2 FREEDOM2-DM1 cohort showed the drug was generally well tolerated, while early results suggested potential clinical benefit.

However, the mixed efficacy data disappointed investors and triggered a sharp selloff in March. The US portion of the trial remains under a partial FDA hold, while approvals in Australia, South Korea and New Zealand allow the study to continue internationally. Its cash runway extends into the second half of 2027, reducing immediate financing pressure.

Technically, PEPG has stabilised above its $2.33 low and is now testing the $2.50 area. Holding around $2.44–$2.50 would keep the recovery setup intact, while a break above $2.62 could open the door to another leg higher.

For now, the stock remains a recovery story in progress, with the next higher-dose data likely to determine whether this rebound can become more sustainable.

$Ford Motor(F.US) 🚘🚗

The last time I posted about Ford, my position was up more than 23%. Since then, the stock has given back most of those gains and is now trading close to my original cost again.

Earlier this week, Ford has signed a long-term agreement with Micron for memory and storage platforms used in next-generation vehicles.

As cars become more software and data-driven, securing this technology could become increasingly important. Ford’s Q2 U.S. sales were also pressured by lower F-150 inventory, making supply reliability another area worth watching.

The Micron deal does not solve that specific issue, but it does show Ford continuing to build the technology infrastructure behind its future vehicles.

With Q2 earnings coming on 28 July, I’m watching whether the recent weakness is temporary.

Still holding. 👀

$Clean Energy Fuels(CLNE.US) has spent weeks hovering around the $2 level, but the underlying story has been developing much faster than the share price.

Recent developments across renewable natural gas production, fleet fueling infrastructure and commercial energy support have continued to strengthen CLNE’s position in lower-carbon fuel infrastructure.

The East Valley Cattle project has moved into RNG production, while CLNE has also expanded its infrastructure footprint through LNG systems in Puerto Rico and continued investment in CNG fueling stations for heavy-duty and commercial fleets.

What I find interesting is how these developments connect. CLNE is not relying on a single project or headline. It is building and operating the infrastructure needed by fleets and commercial users looking to reduce dependence on conventional diesel without waiting for full electrification.

With CLNE finally beginning to move above the range it had been stuck in, I’m watching whether the market is starting to price in that operational progress. For me, the next key question is whether the stock can hold above the $2 level and build sustained momentum through its recent trading range.

$Butterfly Network(BFLY.US)

A Bigger Story

Butterfly Network has become one of my stronger portfolio movers, with the position now showing a major gain after the stock continued pushing higher.

What first made Butterfly interesting to me was its handheld ultrasound technology — a portable and software-driven approach to medical imaging.

The bigger surprise was its five-year co-development and licensing agreement with Midjourney. What makes this interesting is not just BFLY getting an AI-related partner, but Midjourney itself moving into a completely new area beyond image generation.

That gives BFLY a new layer to the story: ultrasound-on-chip, licensing revenue, embedded technology and possible AI imaging applications.

I trimmed some shares to lock in profit, while continuing to hold the rest as momentum kept building. In hindsight it may look early, but partial profit-taking is still part of managing a winning trade.

For me, BFLY is a good reminder that patience can pay when the company story improves before the market fully prices it in.

Sometimes the win is not about selling the exact top — it is about recognising a stronger story, taking some profit, and still letting the rest run.

🦋 In BFLY’s case, the butterfly did not just fly.

It found Midjourney and entered its AI era.

$AMC ENT(AMC.US)

AMC is worth an update because the latest move is not just another random meme-stock spike — there are a few things lining up behind the price action.

The stock recently pushed higher on strong volume, closing around $2.49 after a sharp daily move. What stood out is that volume was meaningfully above its recent average, which suggests this was not just a quiet drift upward.

Fundamentally, the cinema recovery story is also looking better than it did previously. AMC’s Q1 2026 revenue grew 21.2% year-over-year to about $1.045B, attendance improved 13.6%, and adjusted EBITDA turned positive at $38.3M. That matters because AMC has long been weighed down by debt and cash flow concerns, so any sign of stronger operating leverage is worth watching.

The company has also been working on its balance sheet, including refinancing activity and a $425M term loan through its Odeon subsidiary. This does not remove the debt risk completely, but it does give the company more breathing room while it tries to benefit from a stronger box office cycle.

For me, AMC is still a high-risk turnaround and momentum name, not a clean long-term compounder. The key question now is whether the stock can hold its recent move and build above this range, rather than fading back after the volume spike.

Position is currently green, so I’m watching this as a momentum recovery setup with better-than-before fundamentals — but with debt risk still firmly on the checklist.

The AI trade is not dead, but it is becoming more selective. Oracle’s backlog shows demand is still strong, yet the market is now asking whether massive capex can convert into profitable cash flow. From here, I think investors may separate AI beneficiaries from companies carrying heavy funding risk.

$Redwire(RDW.US) 🚀🍓

RDW has been a volatile but interesting trade for me because the stock is moving on both technical momentum and a stronger underlying space infrastructure story.

From a technical point of view, RDW has shown strong momentum after its recent pullback, with buyers stepping back in as the stock recovered. I am watching whether it can continue holding above recent support levels and whether volume stays strong enough to confirm that the move is not just a short-lived spike. For a stock like RDW, I think momentum matters a lot because sentiment can shift very quickly.

On the catalyst side, Redwire recently announced a contract with Astrobiome Space to grow wild strawberries inside Redwire’s Greenhouse aboard the ISS. While the headline sounds fun, I see the bigger point as Redwire proving more use cases for commercial space infrastructure and microgravity research platforms.

The fundamentals also give the trade more substance. In Q1 2026, Redwire reported revenue of $97.0M, YoY growth of 57.9%, gross margin of 26.6%, record backlog of $498.1M, and a book-to-bill ratio of 1.92. To me, the strong backlog suggests demand is there, but the key question is whether Redwire can convert that demand into profitable growth.

I am also mindful of the risks. RDW was recently downgraded by Jefferies from Buy to Hold, even though the price target was raised from $13 to $24. I see that less as a broken thesis and more as a valuation warning after a strong rally. The stock can still have upside, but expectations are higher now.

Overall, my approach with RDW is to treat it as a high-potential but high-volatility space infrastructure trade. I like the long-term story, but for now, I am watching whether RDW can hold its reclaimed levels with volume. If the move loses momentum, I would rather protect gains than chase the space hype blindly.

$Redwire(RDW.US)

RDW has been one of the more interesting space-related names recently, especially with its latest “space strawberries” catalyst.

🍓 Redwire was awarded a contract by Astrobiome Space to grow wild strawberries and test a soil enhancement product inside Redwire’s Greenhouse aboard the ISS. On the surface, it sounds like a fun space agriculture headline. But the more important point is that this marks the inaugural mission for Redwire’s commercial space greenhouse, showing how the company can potentially monetize microgravity research platforms.

This fits into Redwire’s broader space infrastructure story. RDW is not just exposed to one cute catalyst — the company operates across space infrastructure, defense tech, autonomous systems, spacecraft programs, and microgravity research. Its Q1 2026 results also showed strong demand, with revenue of $97.0M, YoY growth of 57.9%, gross margin of 26.6%, record backlog of $498.1M, and a book-to-bill ratio of 1.92.

That said, I would not ignore the risks. RDW was recently downgraded by Jefferies from Buy to Hold, although the price target was also raised from $13 to $24. To me, that sounds less like a broken thesis and more like a valuation warning after a strong rally. The market may still like the space story, but expectations have clearly moved up too.

The key question now is whether Redwire can convert its strong backlog into profitable growth. The backlog shows demand is there, but the company is still working toward consistent profitability.

Overall, I see RDW as a high-potential but volatile space infrastructure play. The “space strawberries” headline is fun, but the real thesis is bigger: commercial space infrastructure, defense demand, and multiple long-term growth angles.